Insights on the Worldwide Optic Nerve Disorders Treatment Industry to 2027 - Featuring Allergan, Novartis & Pfizer Among Others - ResearchAndMarkets.com

DUBLIN--()--The "Optic Nerve Disorders Treatment Market, and Surgery - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.

This report on the global optic nerve disorders treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators for the said market during the forecast period from 2019 to 2027. The report provides the overall market revenue of the optic nerve disorders treatment market for the 2017-2027 period, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the optic nerve disorders treatment market for the forecast period.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the optic nerve disorders treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the optic nerve disorders treatment market.

The report delves into the competitive landscape of the optic nerve disorders treatment market. Key players operating in the optic nerve disorders treatment market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the optic nerve disorders treatment market that have been profiled in this report.

Key Questions Answered

  • What are the sales/revenue generated by each treatment type segment of the optic nerve disorders treatment market across all regions during the forecast period?
  • What are the opportunities in the optic nerve disorders treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which region is likely to expand at the fastest CAGR during the forecast period?
  • Which optic nerve disorders treatment type, indication, and end user segments are expected to generate the maximum revenue globally in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What was the market share or position of different companies operating in the global market in 2018?

Key Topics Covered:

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Optic Nerve Disorders Treatment Market

4. Market Overview
4.1. Introduction
4.1.1. Treatment Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Optic Nerve Disorders Treatment Market Analysis and Forecasts, 2017-2027
4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

6. Global Optic Nerve Disorders Treatment Market Analysis and Forecasts, By Treatment Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Treatment Type, 2017-2027
6.3.1. Pharmacological Treatment
6.3.1.1. Prostaglandins
6.3.1.2. Beta Interferons
6.3.1.3. Beta Blockers
6.3.1.4. Alpha-adrenergic Agonist
6.3.1.5. Carbonic Anhydrase Inhibitors
6.3.1.6. Corticosteroids
6.3.1.7. Combination Drugs
6.3.1.8. Others
6.3.2. Surgery
6.4. Market Attractiveness By Treatment Type, 2019-2027

7. Global Optic Nerve Disorders Treatment Market Analysis and Forecasts, By Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Indication, 2017-2027
7.3.1. Glaucoma
7.3.2. Optic Neuritis
7.3.3. Optic Neuropathy
7.3.3.1. Arteritic ischemic optic neuropathy
7.3.3.2. Non-arteritic ischemic optic neuropathy
7.3.3.3. Congenital Optic Atrophy
7.3.4. Others
7.4. Market Attractiveness By Indication, 2019-2027

8. Global Optic Nerve Disorders Treatment Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2017-2027
8.3.1. Hospitals
8.3.2. Ambulatory Surgery Centers
8.3.3. Clinics
8.3.4. Others
8.4. Market Attractiveness By End-user, 2019-2027

9. Global Optic Nerve Disorders Treatment Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region, 2019-2027

10. North America Optic Nerve Disorders Treatment Market Analysis and Forecast

11. Europe Optic Nerve Disorders Treatment Market Analysis and Forecast

12. Asia Pacific Optic Nerve Disorders Treatment Market Analysis and Forecast

13. Latin America Optic Nerve Disorders Treatment Market Analysis and Forecast

14. Middle East & Africa Optic Nerve Disorders Treatment Market Analysis and Forecast

15. Competition Landscape

Companies Mentioned

  • Santen Pharmaceutical Co., Ltd.
  • Allergan plc.
  • Novartis AG
  • Pfizer, Inc.
  • Bausch Health Companies, Inc.
  • Aerie Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Bionure Farma, S.L.
  • Mallinckrodt Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/r/y5hd7u

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900